Stock Rating Upgrade
During the last several trading days the Value Trend Rating for Integra LifeSciences Holdings Co (NASDAQ: IART) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock closed at $25.22 on 2/7/25 after a decline of -3.1%. Moreover, above average trading volume at 144% of normal accompanied the decline. The stock has declined -4.3% during the last week and has been weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Integra LifeSciences Holdings has a current Value Trend Rating of C (Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Integra LifeSciences Holdings has a good Appreciation Score of 72 but a slightly negative Power Rating of 32, and the Neutral Value Trend Rating results.
Be the first to comment